Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-18 Sale |
2020-12-21 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
12,500 | $26.54 | $331,752 | 162,080 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $27.37 | $95,790 | 519,657 (Indirect Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
18,734 | $30 | $562,035 | 253,416 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-30 Exercise |
2021-01-04 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
3,500 | $2.08 | 170,016 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
3,500 | $0 | 170,016 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,500 | $2.08 | 217,718 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,500 | $0 | 217,718 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
7,143 | $6.22 | 253,416 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
11,591 | $2.08 | 253,416 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
18,734 | $0 | 253,416 (Direct) |
View |
| 2020-10-09 Option Award |
2020-10-13 8:00 pm |
N/A 2030-10-08 |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel |
108,240 | $0 | 108,240 (Direct) |
View |